ReShape Lifesciences (RSLS) announced the signing of an exclusive U.S. distribution agreement with Recon Supply. Through this new strategic partnership, Recon Supply will distribute ReShape’s cutting-edge portfolio, including the STIMEL-03 neuromuscular rehabilitation device, the next-generation Lap-Band 2.0 FLEX, and the full range of ReShape products, across the Veterans Administration and Department of Defense healthcare systems. This collaboration will expand access to proven, life-changing treatments for more than 18 million U.S. veterans and active military personnel.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RSLS:
- Why Is ReShape Lifesciences Stock (RSLS) Down 45% Today?
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories
- ReShape Lifesciences Announces Public Offering Pricing
- ReShape Lifesciences prices 1.054M shares at $2.50 in public offering
- ReShape Lifesciences announces EU MDR certification for European, UK portfolio